Anti-NASH Drug Development Hitches a Lift on PPAR Agonism. [electronic resource]
Producer: 20200916ISSN:- 2073-4409
- Chalcones -- pharmacology
- Diabetes Mellitus, Type 2 -- drug therapy
- Drug Development
- Fatty Liver
- Humans
- Hypoglycemic Agents -- pharmacology
- Inflammation -- pathology
- Liver -- drug effects
- Non-alcoholic Fatty Liver Disease -- drug therapy
- Peroxisome Proliferator-Activated Receptors -- agonists
- Phenylpropionates -- pharmacology
- Pioglitazone -- pharmacology
- Propionates -- pharmacology
- Pyrroles -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.